Presentations to highlight Genprex’s novel gene therapy pipeline in cancer and diabetes
Series to highlight Genprex’s novel gene therapy pipeline in cancer and diabetes
Investor presentations to highlight novel gene therapies for cancer and diabetes and upcoming clinical trials in non-small cell lung cancer
Company overview to highlight novel gene therapies for cancer and diabetes
Investor presentation to highlight novel gene therapies for cancer and diabetes
Investor presentations to highlight novel gene therapies for cancer and diabetes
Company to provide update on upcoming clinical trials for the treatment of non-small cell lung cancer and an overview of its diabetes gene therapy
Thomas Gallagher, Senior VP of Intellectual Property and Licensing, to provide insight into IP best practices to early-stage companies
The 2020 Cell and Gene Meeting on the Mesa will be delivered in a virtual format over the course of five days where attendees will be able to watch company presentations on-demand, in addition to two live-streaming panels each day.
Rodney Varner, Chairman and Chief Executive Officer of Genprex, will present virtually to an online audience on September 1, 2020 at 1:20 p.m. ET.
Designed and Secured by Barsec